- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1335
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of Vav3.1 as prognostic marker in endometrial cancer ; volume:144 ; number:10 ; day:6 ; month:8 ; year:2018 ; pages:2067-2076 ; date:10.2018
Journal of cancer research and clinical oncology ; 144, Heft 10 (6.8.2018), 2067-2076, 10.2018
- Creator
-
Boesch, Maximilian
- Contributor
-
Sopper, Sieghart
Marth, Christian
Fiegl, Heidi
Wiedemair, Annemarie
Rössler, Julia
Hatina, Jiri
Wolf, Dominik
Reimer, Daniel
Zeimet, Alain G.
SpringerLink (Online service)
- DOI
-
10.1007/s00432-018-2725-2
- URN
-
urn:nbn:de:101:1-2018110620204724970041
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boesch, Maximilian
- Sopper, Sieghart
- Marth, Christian
- Fiegl, Heidi
- Wiedemair, Annemarie
- Rössler, Julia
- Hatina, Jiri
- Wolf, Dominik
- Reimer, Daniel
- Zeimet, Alain G.
- SpringerLink (Online service)
Other Objects (12)
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Interpretable prognostic modeling of endometrial cancer
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
CyclinD1, a prominent prognostic marker for endometrial diseases
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Prognostic significance of miR-194 in endometrial cancer
Prognostic impact of CD133 expression in Endometrial Cancer Patients
UBE2T is a diagnostic and prognostic biomarker for endometrial cancer
CCL22 as an independent prognostic factor in endometrial cancer patients
Endometrial cancer
Glycoconjugates as prognostic markers in ovarian cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Interpretable prognostic modeling of endometrial cancer
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
CyclinD1, a prominent prognostic marker for endometrial diseases
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Prognostic significance of miR-194 in endometrial cancer
Prognostic impact of CD133 expression in Endometrial Cancer Patients
UBE2T is a diagnostic and prognostic biomarker for endometrial cancer
CCL22 as an independent prognostic factor in endometrial cancer patients
Endometrial cancer
Glycoconjugates as prognostic markers in ovarian cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Interpretable prognostic modeling of endometrial cancer
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
CyclinD1, a prominent prognostic marker for endometrial diseases
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Prognostic significance of miR-194 in endometrial cancer
Prognostic impact of CD133 expression in Endometrial Cancer Patients
UBE2T is a diagnostic and prognostic biomarker for endometrial cancer
CCL22 as an independent prognostic factor in endometrial cancer patients
Endometrial cancer